In general, CRM1-mediated substrate protein transportation is strictly controlled, but in cancer cells, abnormally high expression of CRM1 often causes abnormal regulation of nuclear-cytoplasmic translocation of proteins, promoting tumorigenesis and tumor progression. The gene discussed is XPO1; the disease is neoplasm.